AB 2352 (Nazarian) Putting decision-making where it should be – between a patient and their physician.
May 2, 2022
May 2, 2022
AB 2352 (Nazarian) makes prescription medication cost information available at the point-of-care, preventing delays in care, medication non-adherence, and reducing administrative burdens on providers and the overall cost of healthcare.
Patients make decisions about their healthcare based on what they can afford. This critical cost and coverage information is not available until after they reach the pharmacy counter, where they may realize a treatment is unaffordable and abandon the needed medication.
Information blocking by insurers and PBMs not only aggravates patients’ state of health, but also leads to increased use of more costly healthcare services such as hospitalizations. This system does not work for patients or our healthcare providers, who are burdened with added administrative responsibilities.
AB 2352 moves prescription drug cost and coverage information into the doctors’ offices at the time of prescribing. Physician and patients are then able to have meaningful conversations about the cost of a specific treatment plan or other available alternatives.
AB 2352 enables decision-making to occur where it should – between a patient and their physician. Support for AB 2352 is critical, and we need your help!
You and/or your organization can help by using these materials on your social media and in your newsletters. Draft letters are available on this page for you to customize, see buttons below.
Please send your questions and letters of support to Alex@ChronicCareCa.org.